6-bromo-7,8-dihydro-5(6H)-quinolinone hydrobromide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-bromo-7,8-dihydro-5(6H)-quinolinone hydrobromide
• 英文别名: 6-bromo-7,8-dihydro-5(6H)-quinolinone, hydrobromide；6-bromo-7,8-dihydro-6H-quinolin-5-one;hydrobromide
• 化学式: BrH*C₉H₈BrNO
• 分子量: 306.985
• InChiKey: BEHKJECAMWDQDO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.55
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  30
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  硒脲 、 6-bromo-7,8-dihydro-5(6H)-quinolinone hydrobromide 以 水 为溶剂， 反应 0.75h， 以40%的产率得到硒杂唑并[4,5-f]喹啉-2-胺,4,5-二氢-
  参考文献：
  名称：

  Shafiee, A.; Rezayazdi, M., Journal of Heterocyclic Chemistry, 1995, vol. 32, # 1, p. 177 - 178

  摘要：

  DOI：
• 作为产物：
  描述：

  5,6,7,8-四氢喹啉-5-酮 在 溴 作用下， 以 氢溴酸 为溶剂， 以9.20 g (88.5%)的产率得到6-bromo-7,8-dihydro-5(6H)-quinolinone hydrobromide
  参考文献：
  名称：

  Hetero [f] fused carbocyclic pyridines as dopaminergic agents

  摘要：

  描述了异构[f]融合的碳环吡啶，以及制备和制备相同的药物组合物的方法，这些药物组合物可作为选择性作用于突触前多巴胺受体的多巴胺激动剂，并可用作多巴胺能、抗精神病和降压剂，以及用于治疗与高催乳素血症相关的疾病和中枢神经系统疾病。

  公开号：

  US04762843A1

文献信息

• Hetero [f] fused carbocyclic pyridines as dopaminergic agents
  申请人：Warner-Lambert Company

  公开号：US04762843A1

  公开（公告）日：1988-08-09

  Hetero [f] fused carbocyclic pyridines are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.

  描述了异构[f]融合的碳环吡啶，以及制备和制备相同的药物组合物的方法，这些药物组合物可作为选择性作用于突触前多巴胺受体的多巴胺激动剂，并可用作多巴胺能、抗精神病和降压剂，以及用于治疗与高催乳素血症相关的疾病和中枢神经系统疾病。
• CAPRATHE, BRADLEY W.;JAEN, JUAN C.;WISE, LAWRENCE D.
  作者：CAPRATHE, BRADLEY W.、JAEN, JUAN C.、WISE, LAWRENCE D.

  DOI：——

  日期：——
• US4762843A
  申请人：——

  公开号：US4762843A

  公开（公告）日：1988-08-09
• Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine
  作者：Bradley W. Caprathe、Juan C. Jaen、Lawrence D. Wise、Thomas G. Heffner、Thomas A. Pugsley、Leonard T. Meltzer、Masood Parvez

  DOI：10.1021/jm00113a010

  日期：1991.9

  A series of rigid tricyclic analogues of the dopamine (DA) agonist PD 118440 [4-(1,2,5,6-tetrahydro-1-propyl-3-pyridinyl)-2-thiazolamine] was synthesized and evaluated for dopaminergic activity and DA autoreceptor selectivity. (R)-(+)-6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine ((+)-6) was identified as the most selective DA autoreceptor agonist from this group of compounds. It inhibited spontaneous locomotor activity (LMA) in rodents, reversed the gamma-butyrolactone (GBL) induced accumulation of rat striatal DOPA and inhibited brain DA neuronal firing, all suggestive of direct DA autoreceptor agonist activity. However, (+)-6 is not completely free of postsynaptic DA activity, as evidenced by its stimulation of LMA in rats at high doses and its ability to produce stereotypy. On the other hand, (-)-6 appears to be a weak partial DA agonist with some effects on brain DA synthesis only at high doses. Like other DA autoreceptor agonists and DA antagonists, (+)-6 inhibited Sidman conditioned avoidance in squirrel monkeys, a test predictive of clinical antipsychotic activity. However, unlike classical antipsychotics, (+)-6 did not induce dystonias in haloperidol-sensitized squirrel monkeys, suggesting a minimal propensity toward extrapyramidal side effects (EPS).
• Shafiee, A.; Rezayazdi, M., Journal of Heterocyclic Chemistry, 1995, vol. 32, # 1, p. 177 - 178
  作者：Shafiee, A.、Rezayazdi, M.

  DOI：——

  日期：——